Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

By Eisenkop S.M.   Spirtos N.M.   Friedman R.L.   Lin W.-C.M.   Pisani A.L.   Perticucci S.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 390-396

Elsevier

Access to resources Recommend Favorite

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

By Karagol Hakan   Saip Pinar   Uygun Kazim   Caloglu Murat   Eralp Yesim   Tas Faruk   Aydiner Adnan   Topuz Erkan  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 39-43

Humana Press, Inc

Access to resources Recommend Favorite

Acute Effects of Pamidronate Administration on Serum Levels of Interleukin-6 in Advanced Solid Tumour Patients with Bone Metastases and their Possible Implications in the Immunotherapy of Cancer with Interleukin-2

By Lissoni P.   Cazzaniga M.   Barni S.   Perego M.S.   Brivio F.   Fumagalli L.   Tancini G.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 304-306

Elsevier

Access to resources Recommend Favorite

Cellular Glutathione Content, in Vitro Chemoresponse, and the Effect of BSO Modulation in Samples Derived from Patients with Advanced Ovarian Cancer

By Lewandowicz G.M.   Britt P.   Elgie A.W.   Williamson C.J.   Coley H.M.   Hall A.G.   Sargent J.M.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 298-304

Academic Press

Access to resources Recommend Favorite

A case of ovarian cancer with remote metastases, with emphasis on changes in tumor marker values

By Mikami M.   Suzuki A.   Takehara K.   Komiyama S.   Ishikawa M.   Hirose T.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 462-465

Elsevier

Access to resources Recommend Favorite